どい書店 do it shoten – おばあちゃん家よりもおばあちゃん家
UrSure developed and commercialized the world's first laboratory-based test for measuring adherence to HIV pre-exposure prophylaxis (PrEP) medications by detecting drug metabolite levels in urine. The company served healthcare providers managing HIV prevention programs and was acquired by OraSure Technologies in May 2020.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountUnknown
May 2020
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
